1.New Development of Anti-HIV Drugs.
Journal of the Korean Medical Association 2001;44(1):86-94
No abstract available.
Anti-HIV Agents*
2.Recent Advances of Antiretroviral Agents.
Korean Journal of Medicine 2016;90(6):481-486
The treatment of human immunodeficiency virus is under constant development. This report reviews recent advances in antiretroviral agents.
Anti-Retroviral Agents*
;
HIV
3.HIV status and related factors among drug-abused prisoners of Quang Ninh detension center
Journal of Preventive Medicine 2007;17(6):30-35
Background: HIV/AIDS has appeared in the early 1980s. Today this disease has become a threat to human. As of 17/3/2006, Vietnam had detected 105,611 cases of HIV infection. Prevalence of abused prisoner in detention centers is quite high. \r\n', u'Objectives: To evaluate the HIV infected status and related factors and to investigate about knowledge, practice of drug-abused prisoners of Quang Ninh detention center on HIV/AIDS prevention.\r\n', u'Subjects and method: A cross-sectional survey was carried out in 346 drug-abused prisoners (338 men, 8 women) of Quang Ninh detention center from June 01 to July 14, 2006.\r\n', u'Results: Prevalence of HIV was 56.07% (CI 95%: 50.9-61.3).Shared syringes increase HIV risk to 5.76 times. Reused syringes increase HIV risk to 7.5 times. Daily drug using increase the risk to 2.46 times. The risk in drug users with more than 5 years increases 12 times. HIV infected rate in cities is 1.92 times more than in rural areas. Good knowledge about non-transmitted behavior was 83%; about 3 ways of transmitions was 50.3%. Knowing about how to detect themselves from HIV only 32.7% have properly answers. Conclusion: HIV prevalence of drug-abused prisoners of Quang Ninh detention center is very high.\r\n', u'\r\n', u'
HIV
;
Anti-HIV Agents/ drug therapy
;
4.Regional Experience of Abacavir: Valuable but Still has Unanswered Question.
Infection and Chemotherapy 2017;49(3):241-242
No abstract available.
Dideoxynucleosides
;
Anti-HIV Agents
;
Reverse Transcriptase Inhibitors
5.Application of HIV-1 Complementation System to Screen the Anti-AIDS Agents That Targets the Late Stage of HIV-1 Replication Cycle.
Ji Yoon RYU ; Soo Young CHOI ; Yung Hi KIM ; Jun Seu PARK
Journal of the Korean Society of Virology 2000;30(3):161-170
No Abstract Available.
Anti-HIV Agents*
;
Complement System Proteins*
;
HIV-1*
6.The effectivement of antiretrovirus combining therapy for HIV positive patients in Hanoi
Journal of Medical and Pharmaceutical Information 2003;0(4):32-35
The study was conducted on 32 HIV positive patients (24 males and 8 females, over 15 years old, with CD4 T-cell counts <350 cell/mm3) who were treated with antiretrovirus therapy (Videx and Zerit) at Dong Da Hospital from Nov 2002 to Oct 2003. The results showed that ARV therapy is effective. The weight, Kanofsky scores, and T CD4 counts of patients were increased significantly after 6 months of treatment. Side effects included fatigue, headache, nausea, but only on first week. Enzyme amylase was increased slightly after 6 months of treatment
Anti-HIV Agents
;
Anti-Retroviral Agents
;
HIV
;
Therapeutics
;
Pharmaceutical Preparations
;
Retroviridae
8.Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China.
Jun-Jie XU ; Xiao-Jie HUANG ; Xin-Chao LIU ; Li-Ming WANG ; Yao-Kai CHEN ; Hui WANG ; Fu-Jie ZHANG ; Hao WU ; Tai-Sheng LI ; Meng-Jie HAN ; Fang ZHAO ; Hai-Bo DING ; Jun-Yi DUAN ; Gen-Shen SHENG ; Hong SHANG
Chinese Medical Journal 2020;133(23):2840-2846
9.A comprehensive overview on the role of phytocompounds in human immunodeficiency virus treatment.
Chinmayee PRIYADARSANI MANDHATA ; Chita RANJAN SAHOO ; Rabindra NATH PADHY
Journal of Integrative Medicine 2023;21(4):332-353
Acquired immune deficiency syndrome (AIDS) is a worldwide epidemic caused by human immunodeficiency virus (HIV) infection. Newer medicines for eliminating the viral reservoir and eradicating the virus are urgently needed. Attempts to locate relatively safe and non-toxic medications from natural resources are ongoing now. Natural-product-based antiviral candidates have been exploited to a limited extent. However, antiviral research is inadequate to counteract for the resistant patterns. Plant-derived bioactive compounds hold promise as powerful pharmacophore scaffolds, which have shown anti-HIV potential. This review focuses on a consideration of the virus, various possible HIV-controlling methods and the recent progress in alternative natural compounds with anti-HIV activity, with a particular emphasis on recent results from natural sources of anti-HIV agents. Please cite this article as: Mandhata CP, Sahoo CR, Padhy RN. A comprehensive overview on the role of phytocompounds in human immunodeficiency virus treatment. J Integr Med. 2023; 21(4):332-353.
Humans
;
HIV
;
HIV Infections/drug therapy*
;
Anti-HIV Agents/therapeutic use*
10.Deep Neck Space Infection Along with Tuberculous Cervical Lymphadenitis in an HIV Patient.
Chang Hoon LEE ; Jin Hee CHO ; Min Sik KIM ; Dong Il SUN
Korean Journal of Otolaryngology - Head and Neck Surgery 2008;51(7):646-649
Recent literature indicates that the incidence of deep neck space infection is on the decline because of the availability of better antibiotics used for upper respiratory infection, but cases of deep neck space infection that do not respond to conventional antibiotic therapy are on the rise. This may be due to reduced immunity, debility, human immunodeficiency virus (HIV) infection, and improper or inadequate treatment. With the emergence of the HIV, the incidence of deep neck space infections and life threatening complications has been on the rise. We describe a case of tuberculous cervical lymphadenitis in an HIV infected patient who developed deep neck space infection and was treated by incision and drainage.
Anti-Bacterial Agents
;
Drainage
;
HIV
;
Humans
;
Incidence
;
Lymphadenitis
;
Neck